07/03/2024 4:27 PM | Arrowhead Pharmaceuticals (Issuer) Oliver Tracie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 5:04 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 1:39 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 1:03 PM | Arrowhead Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/03/2024 5:05 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:30 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/20/2024 6:06 PM | Arrowhead Pharmaceuticals (Issuer) Lu Hongbo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 3:38 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 6:00 PM | Arrowhead Pharmaceuticals (Issuer) Lu Hongbo (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/08/2024 4:54 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:30 PM | Arrowhead Pharmaceuticals (Subject) Myszkowski Kenneth Allen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:25 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:57 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024 4:28 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEFA14A | |
01/24/2024 11:57 AM | Arrowhead Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024 3:14 PM | Arrowhead Pharmaceuticals (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/17/2024 5:32 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:22 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144/A | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Ferrari Mauro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:48 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 3:38 PM | Arrowhead Pharmaceuticals (Subject) Arrowhead Pharmaceuticals (Subject) Waddill William D. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 3:22 PM | Arrowhead Pharmaceuticals (Subject) Ferrari Mauro (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 4:16 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:16 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:17 PM | Arrowhead Pharmaceuticals (Issuer) Oliver Tracie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 6:58 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 7:02 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 4:33 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 4:14 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:39 PM | Arrowhead Pharmaceuticals (Subject) Myszkowski Kenneth Allen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:21 PM | Arrowhead Pharmaceuticals (Subject) San Martin Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:08 PM | Arrowhead Pharmaceuticals (Subject) Oliver Tracie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 4:25 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:27 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 12:49 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 12:06 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 12:25 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
01/04/2024 11:24 AM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:44 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 4:04 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 3:34 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023 2:51 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:52 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:54 PM | Arrowhead Pharmaceuticals (Issuer) OLUKOTUN ADEOYE Y (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:55 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:41 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:16 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 3:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 1:31 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/27/2023 5:23 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:51 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 1:50 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 5:10 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:20 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |